CATO SMS AND PHARM-OLAM MERGE TO CREATE GLOBAL BIOPHARMACEUTICAL SERVICES LEADER
/PRNewswire/ -- News Summary Research Triangle Park, N.C.-based CATO SMS and Bracknell, U.K.-headquartered Pharm-Olam, are merging to create a global...
Stay updated with breaking news from Cato Sms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- News Summary Research Triangle Park, N.C.-based CATO SMS and Bracknell, U.K.-headquartered Pharm-Olam, are merging to create a global...
/PRNewswire/ -- News Summary Research Triangle Park, N.C.-based CATO SMS and Bracknell, U.K.-headquartered Pharm-Olam, are merging to create a global...
CATO SMS Appoints Regulatory Strategy Leader News provided by Share this article CARY, N.C., June 9, 2021 /PRNewswire/ -- CATO SMS , a global provider of specialized clinical research solutions, announced today that it has appointed Dr. Ernesto Vera-Sanchez to vice president of regulatory strategy and head of Good Practices (GxP) consulting services. Dr. Vera-Sanchez, who brings to CATO SMS nearly 20 years of global regulator and inspectorate experience, will spearhead CATO SMS' quality and safety initiatives serving the company's biopharmaceutical clients. Prior to joining CATO SMS, Dr. Ver...
/PRNewswire/ -- CATO SMS, a global provider of regulatory and clinical research services, announced today that it has acquired Nuventra, Inc. to extend its...
CATO SMS Announces Consulting Leadership Appointment Global Provider Appoints Leslie DeVos to Spearhead Continued Expansion of Consulting Capabilities News provided by Share this article Share this article CARY, N.C., March 3, 2021 /PRNewswire/ -- CATO SMS, a global provider of regulatory and clinical research services, announced today that it has appointed Leslie DeVos to president of its consulting business. Ms. DeVos will spearhead the company's continued expansion of its consulting capabilities tailored to the unique needs of small and emerging biopharmaceutical companies. Biopharmace...